NorthWest Biotherapeutics Inc (NWBO)

[HappyLibrarian]

There's little left to debate about DCVax L until we get more material from the Information Arm, the Hospital Exemption program in Germany, EAMS in the UK, or of course the few bits and pieces we can might before the blinded Phase 3 trial is complete such as a full enrollment announcement.

Doubtless, even when we get some or all of this information, the debate over there about DCVax L will probably remain just as vitriolic and childish as it is now until the question is settled once and for all by FDA rejection or approval.